News | October 21, 2023
Evonik strengthens nanoparticle technologies and services portfolio for parenteral drug delivery
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
Alignment of carbon-fiber can be controlled during the 3D printing process
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
PEEK brings a new quality to dental care for patients
The new Biolys provides higher concentration of L-lysine
One thousand times more soluble than L-cystine at neutral pH
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
New agreement applies to the polymers of the Medical Care series portfolio
Subscribe To Our Newsletter & Stay Updated
